Takiishi T, Fenero CIM, Camara NOS. Intestinal barrier and gut microbiota: shaping our immune responses throughout life. Tissue Barriers. 2017;5:e1373208.

PubMed  PubMed Central  Google Scholar 

Li D, Li Y, Yang S, Lu J, Jin X, Wu M. Diet-gut microbiota-epigenetics in metabolic diseases: from mechanisms to therapeutics. Biomed Pharmacother. 2022;153:113290.

CAS  PubMed  Google Scholar 

Caetano-Silva ME, Shrestha A, Duff AF, Kontic D, Brewster PC, Kasperek MC, et al. Aging amplifies a gut microbiota immunogenic signature linked to heightened inflammation. Aging Cell. 2024;23:e14190.

CAS  PubMed  PubMed Central  Google Scholar 

Shieh A, Epeldegui M, Karlamangla AS, Greendale GA. Gut permeability, inflammation, and bone density across the menopause transition. JCI Insight. 2020;5:e134092.

PubMed  PubMed Central  Google Scholar 

Ma Z, Liu Y, Shen W, Yang J, Wang T, Li Y, et al. Osteoporosis in postmenopausal women is associated with disturbances in gut microbiota and migration of peripheral immune cells. BMC Musculoskelet Disord. 2024;25:791.

CAS  PubMed  PubMed Central  Google Scholar 

Cross TL, Simpson AMR, Lin CY, Hottmann NM, Bhatt AP, Pellock SJ, et al. Gut microbiome responds to alteration in female sex hormone status and exacerbates metabolic dysfunction. Gut Microbes. 2024;16:2295429.

PubMed  Google Scholar 

Croze ML, Soulage CO. Potential role and therapeutic interests of myo-inositol in metabolic diseases. Biochimie. 2013;95:1811–27.

CAS  PubMed  Google Scholar 

Mainini G, Ercolano S, De Simone R, Iavarone I, Lizza R, Passaro M. Dietary supplementation of myo-inositol, cocoa polyphenols, and soy isoflavones improves vasomotor symptoms and metabolic profile in menopausal women with metabolic syndrome: a retrospective clinical study. Medicina. 2024;60:598.

PubMed  PubMed Central  Google Scholar 

Iizuka K, Machida T, Hirafuji M. Skeletal muscle is an endocrine organ. J Pharmacol Sci. 2014;125:125–31.

CAS  PubMed  Google Scholar 

Li C, Li Y, Wang N, Ge Z, Shi Z, Wang J, et al. Intestinal Permeability Associated with the Loss of Skeletal Muscle Strength in Middle-Aged and Older Adults in Rural Area of Beijing, China. Healthcare (Basel). 2022;10:1100.

Bivona Iii JJ, Mank MM, Stapleton RD, Files DC, Toth MJ, Poynter ME. Skeletal muscle myofibers directly contribute to LPS-induced systemic inflammatory tone. Front Pharmacol. 2022;13:917917.

PubMed  PubMed Central  Google Scholar 

Alasmari WA, El-Shetry ES, Ibrahim D, ElSawy NA, Eldoumani H, Metwally AS et al. Mesenchymal stem-cells’ exosomes are renoprotective in postmenopausal chronic kidney injury via reducing inflammation and degeneration. Free Radic Biol Med. 2022;182:150–9.

CAS  PubMed  Google Scholar 

Kim JM, Kim JH, Kim K, Shin SC, Cheon YI, Kim HS et al. Tonsil mesenchymal stem cells-derived extracellular vesicles prevent submandibular gland dysfunction in ovariectomized rats. Aging. 2022;14:2194–209.

CAS  PubMed  PubMed Central  Google Scholar 

Cho KA, Choi DW, Kim YH, Kim J, Ryu KH, Woo SY. Mesenchymal stem cell-derived exosomes protect muscle loss by miR-145-5p activity targeting activin a receptors. Cells. 2021;10:2169.

CAS  PubMed  PubMed Central  Google Scholar 

Cho KA, Cha JE, Kim J, Kim YH, Ryu KH, Woo SY. Mesenchymal stem cell-derived exosomes attenuate TLR7-mediated mast cell activation. Tissue Eng Regen Med. 2022;19:117–29.

CAS  PubMed  Google Scholar 

Szulińska M, Łoniewski I, Van Hemert S, Sobieska M, Bogdański P. Dose-dependent effects of multispecies probiotic supplementation on the lipopolysaccharide (LPS) level and cardiometabolic profile in obese postmenopausal women: a 12-week randomized clinical trial. Nutrients. 2018;10:773.

PubMed  PubMed Central  Google Scholar 

Mohammad S, Thiemermann C. Role of metabolic endotoxemia in systemic inflammation and potential interventions. Front Immunol. 2020;11:594150.

CAS  PubMed  Google Scholar 

Mumusoglu S, Yildiz BO. Metabolic syndrome during menopause. Curr Vasc Pharmacol. 2019;17:595–603.

CAS  PubMed  Google Scholar 

Bevilacqua A, Bizzarri M. Inositols in insulin signaling and glucose metabolism. Int J Endocrinol. 2018;2018:1968450.

PubMed  PubMed Central  Google Scholar 

Giordano D, Corrado F, Santamaria A, Quattrone S, Pintaudi B, Di Benedetto A, et al. Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study. Menopause. 2011;18:102–4.

PubMed  Google Scholar 

Pintaudi B, Di Vieste G, Bonomo M. The effectiveness of Myo-inositol and D-chiro inositol treatment in type 2 diabetes. Int J Endocrinol. 2016;2016:9132052.

PubMed  PubMed Central  Google Scholar 

Unfer V, Carlomagno G, Dante G, Facchinetti F. Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials. Gynecol Endocrinol. 2012;28:509–15.

CAS  PubMed  Google Scholar 

Merviel P, James P, Bouee S, Le Guillou M, Rince C, Nachtergaele C, et al. Impact of myo-inositol treatment in women with polycystic ovary syndrome in assisted reproductive technologies. Reprod Health. 2021;18:13.

PubMed  PubMed Central  Google Scholar 

Pachori AS, Madan M, Nunez Lopez YO, Yi F, Meyer C, Seyhan AA. Reduced skeletal muscle secreted frizzled-related protein 3 is associated with inflammation and insulin resistance. Obesity (Silver Spring). 2017;25:697–703.

CAS  PubMed  Google Scholar 

Choi DW, Cho KA, Kim J, Lee HJ, Kim YH, Park JW et al. Extracellular vesicles from tonsil-derived mesenchymal stromal cells show anti-tumor effect via miR-199a-3p. Int J Mol Med. 2021;48:221.

Google Scholar 

Huang X, Liu G, Guo J, Su Z. The PI3K/AKT pathway in obesity and type 2 diabetes. Int J Biol Sci. 2018;14:1483–96.

CAS  PubMed  PubMed Central  Google Scholar 

You M, Xie Z, Zhang N, Zhang Y, Xiao D, Liu S, et al. Signaling pathways in cancer metabolism: mechanisms and therapeutic targets. Signal Transduct Target Ther. 2023;8:196.

CAS  PubMed  PubMed Central  Google Scholar 

Aimaletdinov AM, Gomzikova MO. Tracking of extracellular vesicles' biodistribution: New methods and approaches. Int J Mol Sci. 2022;23:11312.